Adjunctive Team Enhanced Intervention to Improve Suicide Prevention Evidence-Based Practices in Primary Care
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jennifer S Funderburk, PhD
- Phone Number: 315-425-4400
- Email: Jennifer.Funderburk@va.gov
Study Contact Backup
- Name: Michael Kubala
- Email: Michael.Kubala@va.gov
Study Locations
-
-
New York
-
Syracuse, New York, United States, 13210
- Syracuse VA Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Current primary care teamlets of same team within Upstate New York VA primary care clinics
- Must demonstrate stable employment in primary care setting (employed in primary care more than 3 months)
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Standard Practice plus TEACH
Primary care teamlets will receive standard organizational education and support regarding suicide prevention and also engage in Team Education for Adopting Changes in Healthcare (TEACH) huddles.
|
TEACH, an educational strategy which includes evidence-based strategies to improve task-specific teamwork will occur across 4 brief (20-30 minutes) team meetings over a 12-week period.
|
|
No Intervention: Standard Practice
Standard Practice condition will involve the current evidence-based support included in web-based provider-trainings and electronic medical record reminders/templates that are standard within an organization
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Total Score on the Expectancy Rating Scale
Time Frame: baseline and 12-weeks
|
4-item Likert-scaled self-reported questionnaire, Expectancy Rating Scale (ERS) assessing the primary care team's perceived feasibility of TEACH.
The total score ranges from 0 to 40 with higher scores indicating higher feasibility.
|
baseline and 12-weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in total score on the Team Development Measure
Time Frame: baseline and 12-weeks
|
31-item Likert-scaled self-report questionnaire called the Team Development Measure (TDM) that assesses elements of perceived level of teamwork occurring within the primary care teamlet that range in scores from 31 to 124 with higher scores indicating greater teamwork
|
baseline and 12-weeks
|
|
Change in number of patients receiving evidence-based suicide prevention practices based on guidelines
Time Frame: baseline and 16-weeks
|
Electronic medical record data indicating patients receipt (or not) of evidence-based practices
|
baseline and 16-weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SRG-0-064-19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.